| Filed On | Filing |
|---|---|
| 26 Oct 2026 |
Form 4: Perceptive Advisors Llc, Director and 2 others
Received 776,648 shares by exercise or conversion ($777) |
| 26 Oct 2026 | SCHEDULE 13D/A |
| 22 Sep 2026 |
8-K: Other Events
In December 2025, as part of a private placement, LeonaBio, Inc. (the “Company”) issued warrants to purchase an aggregate of 23,031,494 shares of its common stock (the “Series A Common Warrants”). The Series A Common Warrants have an exe... |
| 03 Sep 2026 | Form 3: Portman David J., 10% owner |
| 31 Aug 2026 | SCHEDULE 13D |
| 26 Aug 2026 | 8-K: Other Events |
| 25 Aug 2026 | SCHEDULE 13D/A |
| 20 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | 10-Q |
| 14 Aug 2026 | 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure |
| 10 Jul 2026 |
Form 4: Perceptive Advisors Llc, Director and 2 others
Granted 28,000 Stock Option (Right to Buy) |
| 09 Jul 2026 |
Form 4: Perceptive Advisors Llc, Director and 2 others
Granted 28,000 Stock Option (Right to Buy) |
| 24 Jun 2026 |
Form 4: Callori Fred, Director
Granted 2,333 Stock Option (Right to Buy) |
| 24 Jun 2026 |
Form 4: Holles Natalie C., Director
Granted 2,333 Stock Option (Right to Buy) |
| 24 Jun 2026 |
Form 4: Silverman Peter B., Director
Granted 2,333 Stock Option (Right to Buy) |
| 24 Jun 2026 |
Form 4: Panzara Michael A., Director
Granted 28,000 Stock Option (Right to Buy) |
| 24 Jun 2026 |
Form 4: Romano Kelly A, Director
Granted 28,000 Stock Option (Right to Buy) |
| 24 Jun 2026 |
Form 4: Edelman Joseph, Director
Granted 28,000 Stock Option (Right to Buy) |
| 24 Jun 2026 |
Form 4: Johnson James A, Director
Granted 28,000 Stock Option (Right to Buy) |
| 24 Jun 2026 |
Form 4: Kosacz Barbara, Director
Granted 28,000 Stock Option (Right to Buy) |
Loading...